Thyroid medication and major weight change
Consider whether thyroid replacement monitoring is current after substantial weight change.
Thyroid lab context
Medication-dose review context
Follow-up timing
Symptoms or monitoring notes
A physician safety checklist assistant concept for catching missing monitoring and documentation context before small gaps become preventable misses.
LibraMedical studies how governed intelligence can help clinical teams organize evidence, review checklist context, and keep source-backed questions visible while authority, review, and accountability remain with qualified humans.
LibraMedical does not decide care. It gives the physician a compact review surface for source-backed checklist prompts, missing-context checks, review state, rationale, and traceable evidence.
Virgil can also answer reference questions from approved source packets, manufacturer labels, and guideline anchors. The answer stays in reference territory: source IDs, known warning or interaction-context categories, and related Checklist cards for physician review.
Current research coverage includes five medication contexts and five Virgil reference reports. Each report is validated against source packets and Checklist rules before it can appear in the physician-support lane.
Consider whether thyroid replacement monitoring is current after substantial weight change.
Thyroid lab context
Medication-dose review context
Follow-up timing
Symptoms or monitoring notes
Consider whether metformin-related vitamin B12 and hematologic monitoring context is current.
B12 monitoring context
Hematologic context
Duration or risk-factor notes
Follow-up documentation
Consider whether kidney function and potassium monitoring context is current for a patient taking ACE inhibitor or ARB therapy.
Creatinine or eGFR context
Serum potassium context
Start or dose-change timing
Concurrent medication context
Review whether anticoagulant monitoring context, renal function context, bleeding-related documentation context, interacting medication context, and follow-up timing are current.
Renal function context
Bleeding-related documentation
Interacting medication context
Follow-up timing
Review whether statin adverse-effect documentation context, liver-related context, muscle-symptom context, interacting medication context, and follow-up timing are current.
Liver-related context
Muscle-symptom context
Interacting medication context
Medication list context
A physician-facing note surface highlights checklist context from example inputs without handling patient records.
Each prompt traces to a source packet, freshness register, and review status.
Virgil can surface manufacturer-label and guideline context for physician review, with source IDs, known context categories, and no action taken.
The physician can acknowledge, add to a visit checklist, dismiss with rationale, or open source basis.
Virgil reference transcripts
The current reference set includes five Virgil transcripts. Each answer must stay in reference territory: source context, source IDs, related Checklist card, clinician review only, and no silent action.
Physician asks
What source context is available for thyroid replacement monitoring after substantial weight change and GLP-1 context?
Virgil responds
Reference material reports thyroid replacement monitoring context, substantial body-weight-change context, oral medication absorption context, and follow-up documentation context as source-backed review categories.
Source IDsCLIN-ATA-HYPOTHYROID-2014, CLIN-LEVOXYL-LABEL, CLIN-OZEMPIC-LABEL, CLIN-WEGOVY-LABEL
Related Checklist cardLM-CHECK-THYROID-WEIGHT-001
Physician asks
What source context is available for metformin and vitamin B12 monitoring?
Virgil responds
Reference material reports vitamin B12 and hematologic monitoring context as source-backed review categories for metformin therapy.
Source IDsCLIN-METFORMIN-LABEL-2026, CLIN-ADA-STANDARDS-2026
Related Checklist cardLM-CHECK-METFORMIN-B12-001
Physician asks
What source context is available for ACE inhibitor or ARB kidney and potassium review?
Virgil responds
Reference material reports kidney function, serum potassium, therapy-timing, concurrent medication, and follow-up timing context as source-backed review categories.
Source IDsCLIN-KDIGO-CKD-2024, CLIN-LISINOPRIL-LABEL-2026, CLIN-LOSARTAN-LABEL-2025
Related Checklist cardLM-CHECK-ACEI-ARB-KIDNEY-POTASSIUM-001
Physician asks
What manufacturer or guideline context is available for anticoagulant bleeding-related and renal-function review?
Virgil responds
Reference material reports bleeding-related, renal-function, interacting medication, indication, and follow-up timing context as source-backed review categories.
Source IDsCLIN-ELIQUIS-LABEL-2025, CLIN-XARELTO-LABEL-2026, CLIN-ACC-AHA-AF-2023
Related Checklist cardLM-CHECK-ANTICOAG-BLEEDING-RENAL-001
Physician asks
What source context is available for statin liver-related and muscle-symptom review?
Virgil responds
Reference material reports liver-related, muscle-symptom, interacting medication, medication-list, and follow-up timing context as source-backed review categories.
Source IDsCLIN-ATORVASTATIN-LABEL-2026, CLIN-ROSUVASTATIN-LABEL-2026, CLIN-ACC-AHA-CHOLESTEROL-2018
Related Checklist cardLM-CHECK-STATIN-LIVER-MUSCLE-001
The current lane is built from source packets, validator checks, review queues, claim boundaries, and readiness evidence. A new checklist item must pass review before it can become a rule or cockpit card.
Launch packet
Claims redline guard
Source packet validator
Source review queue
Cockpit interaction harness
Release readiness audit